Micropos Medical AB (MPOS) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK Million (Micro Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.83

Return on Equity

-101.95%

Price to Book

0.00

Revenue and Profits:

Net Sales:

3 Million

(Quarterly Results - Jun 2025)

Net Profit:

-4 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-35.09%

6 Months

-12.46%

1 Year

-39.71%

2 Years

-54.03%

3 Years

-57.38%

4 Years

-53.77%

5 Years

-12.09%

Micropos Medical AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

41.67%

EBIT Growth (5y)

-8.47%

EBIT to Interest (avg)

-19.24

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.12

Sales to Capital Employed (avg)

0.20

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

1.03

EV to EBITDA

1.12

EV to Capital Employed

-4.45

EV to Sales

-2.68

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-78.39%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bearish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 26.92% vs 52.94% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 21.82% vs -19.57% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.30",
          "val2": "2.60",
          "chgp": "26.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.10",
          "val2": "-4.90",
          "chgp": "16.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.30",
          "val2": "-5.50",
          "chgp": "21.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,267.80%",
          "val2": "-2,033.40%",
          "chgp": "76.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 137.50% vs 45.45% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.81% vs -26.34% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.80",
          "val2": "1.60",
          "chgp": "137.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-22.10",
          "val2": "-23.90",
          "chgp": "7.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-21.90",
          "val2": "-23.50",
          "chgp": "6.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-5,831.60%",
          "val2": "-14,643.40%",
          "chgp": "881.18%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

3.30

2.60

26.92%

Operating Profit (PBDIT) excl Other Income

-4.10

-4.90

16.33%

Interest

0.00

0.20

-100.00%

Exceptional Items

0.00

Consolidate Net Profit

-4.30

-5.50

21.82%

Operating Profit Margin (Excl OI)

-1,267.80%

-2,033.40%

76.56%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 26.92% vs 52.94% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 21.82% vs -19.57% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

3.80

1.60

137.50%

Operating Profit (PBDIT) excl Other Income

-22.10

-23.90

7.53%

Interest

0.20

Exceptional Items

0.00

Consolidate Net Profit

-21.90

-23.50

6.81%

Operating Profit Margin (Excl OI)

-5,831.60%

-14,643.40%

881.18%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 137.50% vs 45.45% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 6.81% vs -26.34% in Dec 2023

All Annual Results

Company CV

About Micropos Medical AB

Micropos Medical AB

Pharmaceuticals & Biotechnology

Micropos Medical publ AB is a Sweden-based company engaged in the development of medical devices for high precision four dimensional (4D) radiotherapy. The Company’s first product is RayPilot, an electromagnetic positioning system that enables real time information of the position of the prostate. The system works as an add-on to existing linear accelerators and enables control of a region of interest (ROI) position throughout every radiotherapy session. It consists of RayPilot receiving system, RayPilot transmitter that is placed in the ROI, and RayPilot software. The Company markets its products through sales offices in the Nordic countries, a network of distributors in Europe, the United States and Asia, and through Business to Business (B2B) partnerships with T ex Elekta and Varian & Siemens.

Company Coordinates

Company Details

Adolf Edelsvards Gata 11 , GOETEBORG None : 41451

Tel: 46 31 772814646

http://www.micropos.se/

Registrar Details